0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dry Powder Inhalation Capsules Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-23K16694
Home | Market Reports
Global Dry Powder Inhalation Capsules Market Research Report 2024
BUY CHAPTERS

Global Dry Powder Inhalation Capsules Market Research Report 2026

Code: QYRE-Auto-23K16694
Report
2026-04-10
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dry Powder Inhalation Capsules Market Size

The global Dry Powder Inhalation Capsules market was valued at US$ 942 million in 2025 and is anticipated to reach US$ 1443 million by 2032, at a CAGR of 6.4% from 2026 to 2032.

Dry Powder Inhalation Capsules Market

Dry Powder Inhalation Capsules Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Dry Powder Inhalation Capsules competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Inhalation capsules are a new and successful technique for directly delivering drugs to the respiratory system, providing a focused approach to treating a variety of respiratory disorders. These capsules, also known as dry powder inhalers (DPIs), have gained popularity in the field of respiratory medicine due to their ease of use, portability, and ability to provide immediate relief for people suffering from asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
One of the primary factors leading to inhalation capsules' adoption is their quick onset of action. Unlike oral drugs, which need to pass through the digestive system, inhalation permits the drug to be directly absorbed into the circulation via the respiratory system. This leads to faster therapeutic effects, making inhalation capsules especially useful in instances when a speedy reaction is required, such as emergency treatments or treating acute symptoms. Furthermore, inhalation capsules are ideal for elderly and pediatric patients since they avoid the difficulties associated with ingesting pills or tablets. Inhalation may be a more appealing and less threatening way for children to take medicines.
This report delivers a comprehensive overview of the global Dry Powder Inhalation Capsules market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Dry Powder Inhalation Capsules. The Dry Powder Inhalation Capsules market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Dry Powder Inhalation Capsules market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Dry Powder Inhalation Capsules manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Dry Powder Inhalation Capsules Market Report

Report Metric Details
Report Name Dry Powder Inhalation Capsules Market
Accounted market size in 2025 US$ 942 million
Forecasted market size in 2032 US$ 1443 million
CAGR 6.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Gelatin Capsules
  • Hypromellose Capsules
by Application
  • Asthma Treatment
  • COPD Management
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Capsugel (Lonza), ACG, Qualicaps, HealthCaps India, Cipla, Boehringer Ingelheim GmbH, Elpen S.A., Vectura Group Plc, CHIESI Farmaceutici S.p.A., AstraZeneca Plc, Novartis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Dry Powder Inhalation Capsules manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Dry Powder Inhalation Capsules sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Dry Powder Inhalation Capsules Market growing?

Ans: The Dry Powder Inhalation Capsules Market witnessing a CAGR of 6.4% during the forecast period 2026-2032.

What is the Dry Powder Inhalation Capsules Market size in 2032?

Ans: The Dry Powder Inhalation Capsules Market size in 2032 will be US$ 1443 million.

Who are the main players in the Dry Powder Inhalation Capsules Market report?

Ans: The main players in the Dry Powder Inhalation Capsules Market are Capsugel (Lonza), ACG, Qualicaps, HealthCaps India, Cipla, Boehringer Ingelheim GmbH, Elpen S.A., Vectura Group Plc, CHIESI Farmaceutici S.p.A., AstraZeneca Plc, Novartis

What are the Application segmentation covered in the Dry Powder Inhalation Capsules Market report?

Ans: The Applications covered in the Dry Powder Inhalation Capsules Market report are Asthma Treatment, COPD Management, Others

What are the Type segmentation covered in the Dry Powder Inhalation Capsules Market report?

Ans: The Types covered in the Dry Powder Inhalation Capsules Market report are Gelatin Capsules, Hypromellose Capsules

1 Dry Powder Inhalation Capsules Market Overview
1.1 Product Definition
1.2 Dry Powder Inhalation Capsules by Type
1.2.1 Global Dry Powder Inhalation Capsules Market Value by Type: 2025 vs 2032
1.2.2 Gelatin Capsules
1.2.3 Hypromellose Capsules
1.3 Dry Powder Inhalation Capsules by Application
1.3.1 Global Dry Powder Inhalation Capsules Market Value by Application: 2025 vs 2032
1.3.2 Asthma Treatment
1.3.3 COPD Management
1.3.4 Others
1.4 Global Dry Powder Inhalation Capsules Market Size Estimates and Forecasts
1.4.1 Global Dry Powder Inhalation Capsules Revenue 2021–2032
1.4.2 Global Dry Powder Inhalation Capsules Sales 2021–2032
1.4.3 Global Dry Powder Inhalation Capsules Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Dry Powder Inhalation Capsules Market Competition by Manufacturers
2.1 Global Dry Powder Inhalation Capsules Sales Market Share by Manufacturers (2021–2026)
2.2 Global Dry Powder Inhalation Capsules Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Dry Powder Inhalation Capsules Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Dry Powder Inhalation Capsules, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Dry Powder Inhalation Capsules, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Dry Powder Inhalation Capsules, Product Types and Applications
2.7 Global Key Manufacturers of Dry Powder Inhalation Capsules, Date of Entry into the Industry
2.8 Global Dry Powder Inhalation Capsules Market Competitive Situation and Trends
2.8.1 Global Dry Powder Inhalation Capsules Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Dry Powder Inhalation Capsules Players Market Share by Revenue
2.8.3 Global Dry Powder Inhalation Capsules Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dry Powder Inhalation Capsules Market Scenario by Region
3.1 Global Dry Powder Inhalation Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Dry Powder Inhalation Capsules Sales by Region: 2021–2032
3.2.1 Global Dry Powder Inhalation Capsules Sales by Region: 2021–2026
3.2.2 Global Dry Powder Inhalation Capsules Sales by Region: 2027–2032
3.3 Global Dry Powder Inhalation Capsules Revenue by Region: 2021–2032
3.3.1 Global Dry Powder Inhalation Capsules Revenue by Region: 2021–2026
3.3.2 Global Dry Powder Inhalation Capsules Revenue by Region: 2027–2032
3.4 North America Dry Powder Inhalation Capsules Market Facts & Figures by Country
3.4.1 North America Dry Powder Inhalation Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Dry Powder Inhalation Capsules Sales by Country (2021–2032)
3.4.3 North America Dry Powder Inhalation Capsules Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dry Powder Inhalation Capsules Market Facts & Figures by Country
3.5.1 Europe Dry Powder Inhalation Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Dry Powder Inhalation Capsules Sales by Country (2021–2032)
3.5.3 Europe Dry Powder Inhalation Capsules Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dry Powder Inhalation Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Dry Powder Inhalation Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Dry Powder Inhalation Capsules Sales by Region (2021–2032)
3.6.3 Asia Pacific Dry Powder Inhalation Capsules Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dry Powder Inhalation Capsules Market Facts & Figures by Country
3.7.1 Latin America Dry Powder Inhalation Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Dry Powder Inhalation Capsules Sales by Country (2021–2032)
3.7.3 Latin America Dry Powder Inhalation Capsules Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Dry Powder Inhalation Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Dry Powder Inhalation Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Dry Powder Inhalation Capsules Sales by Country (2021–2032)
3.8.3 Middle East and Africa Dry Powder Inhalation Capsules Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dry Powder Inhalation Capsules Sales by Type (2021–2032)
4.1.1 Global Dry Powder Inhalation Capsules Sales by Type (2021–2026)
4.1.2 Global Dry Powder Inhalation Capsules Sales by Type (2027–2032)
4.1.3 Global Dry Powder Inhalation Capsules Sales Market Share by Type (2021–2032)
4.2 Global Dry Powder Inhalation Capsules Revenue by Type (2021–2032)
4.2.1 Global Dry Powder Inhalation Capsules Revenue by Type (2021–2026)
4.2.2 Global Dry Powder Inhalation Capsules Revenue by Type (2027–2032)
4.2.3 Global Dry Powder Inhalation Capsules Revenue Market Share by Type (2021–2032)
4.3 Global Dry Powder Inhalation Capsules Price by Type (2021–2032)
5 Segment by Application
5.1 Global Dry Powder Inhalation Capsules Sales by Application (2021–2032)
5.1.1 Global Dry Powder Inhalation Capsules Sales by Application (2021–2026)
5.1.2 Global Dry Powder Inhalation Capsules Sales by Application (2027–2032)
5.1.3 Global Dry Powder Inhalation Capsules Sales Market Share by Application (2021–2032)
5.2 Global Dry Powder Inhalation Capsules Revenue by Application (2021–2032)
5.2.1 Global Dry Powder Inhalation Capsules Revenue by Application (2021–2026)
5.2.2 Global Dry Powder Inhalation Capsules Revenue by Application (2027–2032)
5.2.3 Global Dry Powder Inhalation Capsules Revenue Market Share by Application (2021–2032)
5.3 Global Dry Powder Inhalation Capsules Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Capsugel (Lonza)
6.1.1 Capsugel (Lonza) Company Information
6.1.2 Capsugel (Lonza) Description and Business Overview
6.1.3 Capsugel (Lonza) Dry Powder Inhalation Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Capsugel (Lonza) Dry Powder Inhalation Capsules Product Portfolio
6.1.5 Capsugel (Lonza) Recent Developments/Updates
6.2 ACG
6.2.1 ACG Company Information
6.2.2 ACG Description and Business Overview
6.2.3 ACG Dry Powder Inhalation Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 ACG Dry Powder Inhalation Capsules Product Portfolio
6.2.5 ACG Recent Developments/Updates
6.3 Qualicaps
6.3.1 Qualicaps Company Information
6.3.2 Qualicaps Description and Business Overview
6.3.3 Qualicaps Dry Powder Inhalation Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Qualicaps Dry Powder Inhalation Capsules Product Portfolio
6.3.5 Qualicaps Recent Developments/Updates
6.4 HealthCaps India
6.4.1 HealthCaps India Company Information
6.4.2 HealthCaps India Description and Business Overview
6.4.3 HealthCaps India Dry Powder Inhalation Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 HealthCaps India Dry Powder Inhalation Capsules Product Portfolio
6.4.5 HealthCaps India Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Dry Powder Inhalation Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cipla Dry Powder Inhalation Capsules Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Boehringer Ingelheim GmbH
6.6.1 Boehringer Ingelheim GmbH Company Information
6.6.2 Boehringer Ingelheim GmbH Description and Business Overview
6.6.3 Boehringer Ingelheim GmbH Dry Powder Inhalation Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Boehringer Ingelheim GmbH Dry Powder Inhalation Capsules Product Portfolio
6.6.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.7 Elpen S.A.
6.7.1 Elpen S.A. Company Information
6.7.2 Elpen S.A. Description and Business Overview
6.7.3 Elpen S.A. Dry Powder Inhalation Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Elpen S.A. Dry Powder Inhalation Capsules Product Portfolio
6.7.5 Elpen S.A. Recent Developments/Updates
6.8 Vectura Group Plc
6.8.1 Vectura Group Plc Company Information
6.8.2 Vectura Group Plc Description and Business Overview
6.8.3 Vectura Group Plc Dry Powder Inhalation Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Vectura Group Plc Dry Powder Inhalation Capsules Product Portfolio
6.8.5 Vectura Group Plc Recent Developments/Updates
6.9 CHIESI Farmaceutici S.p.A.
6.9.1 CHIESI Farmaceutici S.p.A. Company Information
6.9.2 CHIESI Farmaceutici S.p.A. Description and Business Overview
6.9.3 CHIESI Farmaceutici S.p.A. Dry Powder Inhalation Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 CHIESI Farmaceutici S.p.A. Dry Powder Inhalation Capsules Product Portfolio
6.9.5 CHIESI Farmaceutici S.p.A. Recent Developments/Updates
6.10 AstraZeneca Plc
6.10.1 AstraZeneca Plc Company Information
6.10.2 AstraZeneca Plc Description and Business Overview
6.10.3 AstraZeneca Plc Dry Powder Inhalation Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 AstraZeneca Plc Dry Powder Inhalation Capsules Product Portfolio
6.10.5 AstraZeneca Plc Recent Developments/Updates
6.11 Novartis
6.11.1 Novartis Company Information
6.11.2 Novartis Description and Business Overview
6.11.3 Novartis Dry Powder Inhalation Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Novartis Dry Powder Inhalation Capsules Product Portfolio
6.11.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dry Powder Inhalation Capsules Industry Chain Analysis
7.2 Dry Powder Inhalation Capsules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dry Powder Inhalation Capsules Production Mode & Process Analysis
7.4 Dry Powder Inhalation Capsules Sales and Marketing
7.4.1 Dry Powder Inhalation Capsules Sales Channels
7.4.2 Dry Powder Inhalation Capsules Distributors
7.5 Dry Powder Inhalation Capsules Customer Analysis
8 Dry Powder Inhalation Capsules Market Dynamics
8.1 Dry Powder Inhalation Capsules Industry Trends
8.2 Dry Powder Inhalation Capsules Market Drivers
8.3 Dry Powder Inhalation Capsules Market Challenges
8.4 Dry Powder Inhalation Capsules Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Dry Powder Inhalation Capsules Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Dry Powder Inhalation Capsules Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Dry Powder Inhalation Capsules Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Dry Powder Inhalation Capsules Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Dry Powder Inhalation Capsules Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Dry Powder Inhalation Capsules Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Dry Powder Inhalation Capsules Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Dry Powder Inhalation Capsules Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Dry Powder Inhalation Capsules, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Dry Powder Inhalation Capsules, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Dry Powder Inhalation Capsules, Product Types and Applications
 Table 12. Global Key Manufacturers of Dry Powder Inhalation Capsules, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dry Powder Inhalation Capsules Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dry Powder Inhalation Capsules Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dry Powder Inhalation Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Dry Powder Inhalation Capsules Sales by Region (K Units), 2021–2026
 Table 18. Global Dry Powder Inhalation Capsules Sales Market Share by Region (2021–2026)
 Table 19. Global Dry Powder Inhalation Capsules Sales by Region (K Units), 2027–2032
 Table 20. Global Dry Powder Inhalation Capsules Sales Market Share by Region (2027–2032)
 Table 21. Global Dry Powder Inhalation Capsules Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Dry Powder Inhalation Capsules Revenue Market Share by Region (2021–2026)
 Table 23. Global Dry Powder Inhalation Capsules Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Dry Powder Inhalation Capsules Revenue Market Share by Region (2027–2032)
 Table 25. North America Dry Powder Inhalation Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Dry Powder Inhalation Capsules Sales by Country (K Units), 2021–2026
 Table 27. North America Dry Powder Inhalation Capsules Sales by Country (K Units), 2027–2032
 Table 28. North America Dry Powder Inhalation Capsules Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Dry Powder Inhalation Capsules Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Dry Powder Inhalation Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Dry Powder Inhalation Capsules Sales by Country (K Units), 2021–2026
 Table 32. Europe Dry Powder Inhalation Capsules Sales by Country (K Units), 2027–2032
 Table 33. Europe Dry Powder Inhalation Capsules Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Dry Powder Inhalation Capsules Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Dry Powder Inhalation Capsules Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Dry Powder Inhalation Capsules Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Dry Powder Inhalation Capsules Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Dry Powder Inhalation Capsules Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Dry Powder Inhalation Capsules Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Dry Powder Inhalation Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Dry Powder Inhalation Capsules Sales by Country (K Units), 2021–2026
 Table 42. Latin America Dry Powder Inhalation Capsules Sales by Country (K Units), 2027–2032
 Table 43. Latin America Dry Powder Inhalation Capsules Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Dry Powder Inhalation Capsules Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Dry Powder Inhalation Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Dry Powder Inhalation Capsules Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Dry Powder Inhalation Capsules Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Dry Powder Inhalation Capsules Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Dry Powder Inhalation Capsules Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Dry Powder Inhalation Capsules Sales (K Units) by Type (2021–2026)
 Table 51. Global Dry Powder Inhalation Capsules Sales (K Units) by Type (2027–2032)
 Table 52. Global Dry Powder Inhalation Capsules Sales Market Share by Type (2021–2026)
 Table 53. Global Dry Powder Inhalation Capsules Sales Market Share by Type (2027–2032)
 Table 54. Global Dry Powder Inhalation Capsules Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Dry Powder Inhalation Capsules Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Dry Powder Inhalation Capsules Revenue Market Share by Type (2021–2026)
 Table 57. Global Dry Powder Inhalation Capsules Revenue Market Share by Type (2027–2032)
 Table 58. Global Dry Powder Inhalation Capsules Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Dry Powder Inhalation Capsules Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Dry Powder Inhalation Capsules Sales (K Units) by Application (2021–2026)
 Table 61. Global Dry Powder Inhalation Capsules Sales (K Units) by Application (2027–2032)
 Table 62. Global Dry Powder Inhalation Capsules Sales Market Share by Application (2021–2026)
 Table 63. Global Dry Powder Inhalation Capsules Sales Market Share by Application (2027–2032)
 Table 64. Global Dry Powder Inhalation Capsules Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Dry Powder Inhalation Capsules Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Dry Powder Inhalation Capsules Revenue Market Share by Application (2021–2026)
 Table 67. Global Dry Powder Inhalation Capsules Revenue Market Share by Application (2027–2032)
 Table 68. Global Dry Powder Inhalation Capsules Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Dry Powder Inhalation Capsules Price (US$/Unit) by Application (2027–2032)
 Table 70. Capsugel (Lonza) Company Information
 Table 71. Capsugel (Lonza) Description and Business Overview
 Table 72. Capsugel (Lonza) Dry Powder Inhalation Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Capsugel (Lonza) Dry Powder Inhalation Capsules Product
 Table 74. Capsugel (Lonza) Recent Developments/Updates
 Table 75. ACG Company Information
 Table 76. ACG Description and Business Overview
 Table 77. ACG Dry Powder Inhalation Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. ACG Dry Powder Inhalation Capsules Product
 Table 79. ACG Recent Developments/Updates
 Table 80. Qualicaps Company Information
 Table 81. Qualicaps Description and Business Overview
 Table 82. Qualicaps Dry Powder Inhalation Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Qualicaps Dry Powder Inhalation Capsules Product
 Table 84. Qualicaps Recent Developments/Updates
 Table 85. HealthCaps India Company Information
 Table 86. HealthCaps India Description and Business Overview
 Table 87. HealthCaps India Dry Powder Inhalation Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. HealthCaps India Dry Powder Inhalation Capsules Product
 Table 89. HealthCaps India Recent Developments/Updates
 Table 90. Cipla Company Information
 Table 91. Cipla Description and Business Overview
 Table 92. Cipla Dry Powder Inhalation Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Cipla Dry Powder Inhalation Capsules Product
 Table 94. Cipla Recent Developments/Updates
 Table 95. Boehringer Ingelheim GmbH Company Information
 Table 96. Boehringer Ingelheim GmbH Description and Business Overview
 Table 97. Boehringer Ingelheim GmbH Dry Powder Inhalation Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Boehringer Ingelheim GmbH Dry Powder Inhalation Capsules Product
 Table 99. Boehringer Ingelheim GmbH Recent Developments/Updates
 Table 100. Elpen S.A. Company Information
 Table 101. Elpen S.A. Description and Business Overview
 Table 102. Elpen S.A. Dry Powder Inhalation Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Elpen S.A. Dry Powder Inhalation Capsules Product
 Table 104. Elpen S.A. Recent Developments/Updates
 Table 105. Vectura Group Plc Company Information
 Table 106. Vectura Group Plc Description and Business Overview
 Table 107. Vectura Group Plc Dry Powder Inhalation Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Vectura Group Plc Dry Powder Inhalation Capsules Product
 Table 109. Vectura Group Plc Recent Developments/Updates
 Table 110. CHIESI Farmaceutici S.p.A. Company Information
 Table 111. CHIESI Farmaceutici S.p.A. Description and Business Overview
 Table 112. CHIESI Farmaceutici S.p.A. Dry Powder Inhalation Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. CHIESI Farmaceutici S.p.A. Dry Powder Inhalation Capsules Product
 Table 114. CHIESI Farmaceutici S.p.A. Recent Developments/Updates
 Table 115. AstraZeneca Plc Company Information
 Table 116. AstraZeneca Plc Description and Business Overview
 Table 117. AstraZeneca Plc Dry Powder Inhalation Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. AstraZeneca Plc Dry Powder Inhalation Capsules Product
 Table 119. AstraZeneca Plc Recent Developments/Updates
 Table 120. Novartis Company Information
 Table 121. Novartis Description and Business Overview
 Table 122. Novartis Dry Powder Inhalation Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Novartis Dry Powder Inhalation Capsules Product
 Table 124. Novartis Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Dry Powder Inhalation Capsules Distributors List
 Table 128. Dry Powder Inhalation Capsules Customers List
 Table 129. Dry Powder Inhalation Capsules Market Trends
 Table 130. Dry Powder Inhalation Capsules Market Drivers
 Table 131. Dry Powder Inhalation Capsules Market Challenges
 Table 132. Dry Powder Inhalation Capsules Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dry Powder Inhalation Capsules
 Figure 2. Global Dry Powder Inhalation Capsules Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Dry Powder Inhalation Capsules Market Share by Type: 2025 & 2032
 Figure 4. Gelatin Capsules Product Picture
 Figure 5. Hypromellose Capsules Product Picture
 Figure 6. Global Dry Powder Inhalation Capsules Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Dry Powder Inhalation Capsules Market Share by Application: 2025 & 2032
 Figure 8. Asthma Treatment
 Figure 9. COPD Management
 Figure 10. Others
 Figure 11. Global Dry Powder Inhalation Capsules Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Dry Powder Inhalation Capsules Market Size (US$ Million), 2021–2032
 Figure 13. Global Dry Powder Inhalation Capsules Sales (K Units), 2021–2032
 Figure 14. Global Dry Powder Inhalation Capsules Average Price (US$/Unit), 2021–2032
 Figure 15. Dry Powder Inhalation Capsules Report Years Considered
 Figure 16. Dry Powder Inhalation Capsules Sales Share by Manufacturers in 2025
 Figure 17. Global Dry Powder Inhalation Capsules Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Dry Powder Inhalation Capsules Players: Market Share by Revenue in Dry Powder Inhalation Capsules in 2025
 Figure 19. Dry Powder Inhalation Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Dry Powder Inhalation Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Dry Powder Inhalation Capsules Sales Market Share by Country (2021–2032)
 Figure 22. North America Dry Powder Inhalation Capsules Revenue Market Share by Country (2021–2032)
 Figure 23. United States Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Dry Powder Inhalation Capsules Sales Market Share by Country (2021–2032)
 Figure 26. Europe Dry Powder Inhalation Capsules Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Dry Powder Inhalation Capsules Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Dry Powder Inhalation Capsules Revenue Market Share by Region (2021–2032)
 Figure 34. China Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Dry Powder Inhalation Capsules Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Dry Powder Inhalation Capsules Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Dry Powder Inhalation Capsules Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Dry Powder Inhalation Capsules Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Dry Powder Inhalation Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Dry Powder Inhalation Capsules by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Dry Powder Inhalation Capsules by Type (2021–2032)
 Figure 54. Global Dry Powder Inhalation Capsules Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Dry Powder Inhalation Capsules by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Dry Powder Inhalation Capsules by Application (2021–2032)
 Figure 57. Global Dry Powder Inhalation Capsules Price (US$/Unit) by Application (2021–2032)
 Figure 58. Dry Powder Inhalation Capsules Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network